Goniothalamin induces apoptosis in vascular smooth muscle cells

Chemico-Biological Interactions

Volumn 159, Issue 2, 2006, Pages 129-140

  Chan, K M ^a   Rajab, N F ^a   Ishak, M H A ^a   Ali, A M ^b   Yusoff, K ^c   Din, L B ^a   Inayat Hussain, S H ^a,d  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^b UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^c UNIVERSITI TEKNOLOGI MARA   (Malaysia)

^d UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

Author keywords

Apoptosis; Cytotoxicity; DNA damage; Goniothalamin; VSMCs

Indexed keywords

BROXURIDINE; GONIOTHALAMIN; PACLITAXEL; PLANT EXTRACT; RAPAMYCIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; COMET ASSAY; CONCENTRATION RESPONSE; CYTOTOXICITY; DNA DAMAGE; DRUG STRUCTURE; HUMAN; IC 50; RESTENOSIS; SMOOTH MUSCLE FIBER; STATISTICAL ANALYSIS;

APOPTOSIS; BROMODEOXYURIDINE; CELL DIVISION; CELLS, CULTURED; COMET ASSAY; HUMANS; MUSCLE, SMOOTH, VASCULAR; PYRONES;

EID: 29944433590     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2005.10.107     Document Type: Article

References (45)

1. R. Fattori, and T. Piva Drug-eluting stents in vascular intervention Lancet 361 2003 247 249
2. M.R. Bennett, and M. O'Sullivan Mechanisms of angioplasty and stent restenosis: implications for design of rational therapy Pharmacol. Ther. 91 2001 149 166
3. J. Li, P.F. Li, R. Dietz, and R. von Harsdorf Intracellular superoxide induces apoptosis in VSMCs: role of mitochondrial membrane potential, cytochrome c and caspases Apoptosis 7 2002 511 517
4. C. Indolfi, A. Mongiardo, A. Curcio, and D. Torella Molecular mechanisms of in-stent restenosis and approach to therapy with eluting stents Trends Cardiovas. Med. 13 2003 142 148
5. M.R. Bennet In-stent stenosis: pathology and implications for the development of drug eluting-stents Heart 89 2003 218 224
6. H.M. Yang, H.S. Kim, K.Y. Park, H.J. You, S.I. Jeon, S.W. Youn, S.H. Kim, B.H. Oh, M.M. Lee, Y.B. Park, and K. Walsh Celecoxib, a cyclooygenase-2 inhibitor, reduces neointimal hyperplasia through inhibition of Akt signalling Circulation 110 2004 301 308
7. V. Lesauskaitè, L. Ivanovienè, and A. Valenčiū tè Programmed cellular death and atherogenesis: from molecular mechanisms clinical aspects Medicina 39 2003 529 534
8. S.H. Inayat-Hussain, A.B. Osman, L.B. Din, A.M. Ali, R.T. Snowden, M. MacFarlane, and K. Cain Caspases-3 and -7 are activated in goniothalamin-induced apoptosis in human Jurkat T-cells FEBS Lett. 456 1999 379 383
9. S.H. Inayat-Hussain, and N.F. Thomas Recent advances in the discovery and development of stilbenes and lactones in anticancer therapy Expert Opin. Ther. Patents 14 2004 1 16
10. H.B. Mereyala, and M. Joe Cytotoxic activity of styryl lactones and their derivatives Curr. Med. Chem. Anti-Can. Agents 1 2001 293 300
11. I.B. Jantan, F.B. Ahmad, and L.B. Din Chemical constituents of the bark oil of Goniothalamus macrophyllus Hook. f. from Malaysia J. Essential Oil Res. JOER 17 2005 181 183
12. T.W. Sam, S.Y. Chew, S. Matsjeh, E.K. Gan, D. Razak, and A.L. Mohamed Goniothalamin oxide - an embryotoxic compound from Goniothalamus macrophyllus (Annonaceae) Tetrahedron Lett. 28 1987 2541 2544
13. K. Jewers, J.B. Davis, J. Dougan, A.H. Machanda, G. Blunden, A. Kyi, and S. Wetchaipan Goniothalamin and its distribution in four Goniothalamus species Phytochemistry 11 1972 2025 2030
14. M.A. Mosaddik, and M.E. Haque Cytotoxicity and antimicrobial activity of goniothalamin isolated from Bryonopsis laciniosa Phytother. Res. 17 2003 1155 1157
15. K.E. Kabir, A.R. Khan, and M.A. Mosaddik Goniothalamin - a potent mosquito larvicide from Bryonopsis laciniosa J. App. Ent. 127 2003 112 115
16. M. Tsubuki, K. Kanai, H. Nagase, and T. Honda Stereocontrolled syntheses of novel styryl lactones, (+)-goniodiol, (+)-goniotriol, (+)-8-acetylgoniotriol, (+)-goniofufurone, (+)-9-deoxygoniopypyrone, (+)-goniopypyrone, and (+)-altholactone from common intermediates and cytotoxicity of their congeners Tetrahedron 55 1999 2493 2514
17. A.M. Ali, M.M. Mackeen, M. Hamid, Q.B. Aun, Y. Zauyah, H.L. Azimahtol, and K. Kawazu Cytotoxicity and electron microscopy of cell death induced by goniothalamin Planta Med. 63 1997 81 83
18. A.M. Ali, N. Umar-Tsafe, S.M. Mohamed, S.H. Inayat-Hussein, K.T. Oo, K. Yusoff, A.B. Osman, and L.B. Din Apoptosis induction in CEM-SS T-lymphoblastic leukemic cell line by goniothalamin J. Biochem. Mol. Biol. Biophys. 5 2001 253 261
19. A.T.C. Lee, H.L.P. Azimahtol, and A.N. Tan Styrylpyrone derivative (SPD) induces apoptosis in a caspase-7-dependent manner in the human breast cancer cell line MCF-7 Cancer Cell Int. 3 2003 1 8
20. S.H. Inayat-Hussain, A.B. Osman, L.B. Din, A.M. Ali, and D. Ross Loss of mitochondrial transmembrane potential and caspase-9 activation during apoptosis induced by novel styryl-lactone goniothalamin in HL-60 leukemia cells Toxicol. In Vitro 17 2003 433 439
21. V.J. McKelvey-Martin, E.T. Ho, S.R. McKeown, S.R. Johnston, P.J. McCarthy, N.F. Rajab, and C.S. Downes Emerging applications of the single cell gel electrophoresis (Comet) assay. I. Management of invasive transitional cell human bladder carcinoma. II. Fluorescent in situ hybridization Comets for the identification of damaged and repaired DNA sequences in individual cells Mutagenesis 13 1998 1 8
22. A.R. Collins, V.L. Dobson, M. Duinská, G. Kennedy, and R. ttina The comet assay: what can it really tell us? Mutat. Res. 375 1997 183 193
23. A. Wong, and C. Chan Drug-eluting stents: the end of restenosis? Ann. Acad. Med. Singapore 33 2004 423 431
24. T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Meth. 65 1983 55 63
25. A. Hawariah, and J. Stanslas In vitro response of human breast cancer cell lines to growth-inhibitory effects of styrylpyrone derivative (SPD) and assessment of its antiestrogenicity Anticancer Res. 18 1998 4383 4386
26. A.H. Pihie, J. Stanslas, and L.B. Din Non-steroid receptor-mediated antiproliferative activity of styrylpyrone derivative in human breast cancer cell lines Anticancer Res. 18 1998 1739 1743
27. Z. Darzynkiewicz, D. Evenson, J. Kapuscinski, and M.R. Melamed Denaturation of RNA and DNA in situ induced by acridine orange Exp. Cell Res. 148 1983 31 46
28. M. Raffray, and G.M. Cohen Apoptosis and necrosis in toxicology: a continuum or distinct modes of cell death Pharmacol. Ther. 75 1997 153 177
29. V.E. Stoneman, and M.R. Bennett Role of apoptosis in atherosclerosis and its therapeutic implications Clin. Sci. 107 2004 343 354
30. J.M. McKim Jr., P.C. Wilga, J.F. Pregenzer, and D.K. Petrella A biochemical approach to in vitro toxicity testing Pharm. Discov. 2005
31. A. Hague, G.D. Diaz, D.J. Hicks, S. Krajewski, J.C. Reed, and C. Paraskeva bcl-2 and bak may play a pivotal role in sodium butyrate-induced apoptosis in colonic epithelial cells; however overexpression of bcl-2 does not protect against bak mediated apoptosis Int. J. Cancer 72 1997 898 905
32. E. Ulukaya, M. Colakogullari, and E.J. Wood Interference by anti-cancer chemotherapeutic agents in the MTT-tumor chemosensitivity assay Chemotherapy 50 2004 43 50
33. H.G. Gratzner Monoclonal antibody to 5-bromo-2 and 5-iododeoxyuridine: a new reagent for detection of DNA replication Science 218 1982 474 475
34. E.J. Brown, M.W. Albers, T.B. Shin, K. Ichikawa, C.T. Keith, W.J. Lane, and S.L. Schreiber A mammalian protein targeted by G2-arresting rapamycin-receptor complex Nature 368 1994 756 758
35. S. Orrenius Apoptosis: molecular mechanisms and implications for human disease J. Int. Med. 137 1995 529 539
36. A. Haunstetter, and S. Izumo Apoptosis - basic mechanisms and implications for cardiovascular disease Circ. Res. 82 1998 1111 1129
37. N.A. Bourbon, J. Yun, D. Berkey, Y. Wang, and M. Kester Inhibitory action of ceramide upon PKC-epsilon/ERK interactions Am. J. Cell Physiol. 280 2001 C1403 C1411
38. S. Scott, M. O'Sullivan, S. Hafizi, L.M. Shapiro, and M.R. Bennett Human vascular smooth muscle cells from restenosis or in-stent stenosis sites demonstrate enhanced responses to p53: implications for brachytherapy and drug treatment for restenosis Circ. Res. 90 2002 398 404
39. L.J. Hofseth, S.P. Hussain, and C.C. Harris p53: 25 years after its discovery Trends Pharmcol. Sci. 25 2004 177 181
40. R.R. Tice, E. Agurell, D. Anderson, B. Burlinson, A. Hartmann, H. Kobayashi, Y. Miyamae, E. Rojas, J.C. Ryu, and Y.F. Sasaki Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing Environ. Mol. Mutagen. 35 2000 206 221
41. N.P. Singh, M.T. McCoy, R.R. Tice, and E.L. Schneider A simple technique for quantitation of low levels of DNA damage in individual cells Exp. Cell Res. 175 1988 184 191
42. L. Henderson, A. Wolfreys, J. Fedyk, C. Bourner, and S. Windebank The ability of comet assay to discriminate between genotoxins and cytotoxins Mutagenesis 13 1998 89 94
43. D.L. Dehn, S.H. Inayat-Hussain, and D. Ross RH1 induces cellular damage in an NAD(P)H:quinone oxidoreductase 1-dependent manner: relationship between DNA cross-linking, cell cycle perturbations, and apoptosis J. Pharmacol. Exp. Ther. 313 2005 771 779
44. A.R. Collins, V.L. Dobson, M. Dusinska, G. Kennedy, and R. Stetina The comet assay: what can it really tell us? Mutat. Res. 375 2 1997 183 193
45. P.L. Olive DNA damage and repair in individual cells: applications of the comet assay in radiobiology Int. J. Radiat. Biol. 75 1999 395 405